Synthesis and in vitro Anticancer Activity of Ruthenium-Cymene Complexes with Cyclohexyl-Functionalized Ethylenediamine-N,N′-diacetate-Type Ligands

Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and n‐butyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1H, and 13C NMR characterizat...

Full description

Saved in:
Bibliographic Details
Published inChemMedChem Vol. 6; no. 10; pp. 1884 - 1891
Main Authors Savić, Aleksandar, Dulović, Marija, Poljarević, Jelena M., Misirlić-Denčić, Sonja, Jovanović, Maja, Bogdanović, Andrija, Trajković, Vladimir, Sabo, Tibor J., Grgurić-Šipka, Sanja, Marković, Ivanka
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 04.10.2011
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and n‐butyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1H, and 13C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL‐60, K562, and REH cells (IC50: 1.0–20.2 μM), with the n‐butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n‐butyl ester complex is more effective against leukemic patients′ blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of RuII‐based compounds. Mitochondria depolarized! Novel ruthenium(II) arene complexes containing alkyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid as chelating agents show potent selective antitumor activity. They induce apoptosis via a mitochondrial pathway involving mechanisms different from those induced by platinum‐based drugs.
AbstractList Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and n‐butyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1H, and 13C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL‐60, K562, and REH cells (IC50: 1.0–20.2 μM), with the n‐butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n‐butyl ester complex is more effective against leukemic patients′ blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of RuII‐based compounds. Mitochondria depolarized! Novel ruthenium(II) arene complexes containing alkyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid as chelating agents show potent selective antitumor activity. They induce apoptosis via a mitochondrial pathway involving mechanisms different from those induced by platinum‐based drugs.
Herein we describe the synthesis, characterization, and anticancer activity of novel p-cymeneruthenium(II) complexes containing methyl, ethyl, n-propyl, and n-butyl esters of (S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, (1)H, and (13)C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL-60, K562, and REH cells (IC(50): 1.0-20.2 μM), with the n-butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n-butyl ester complex is more effective against leukemic patients' blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of Ru(II)-based compounds.
Abstract Herein we describe the synthesis, characterization, and anticancer activity of novel p ‐cymeneruthenium(II) complexes containing methyl, ethyl, n ‐propyl, and n ‐butyl esters of ( S , S )‐ethylenediamine‐ N , N′ ‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1 H, and 13 C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL‐60, K562, and REH cells (IC 50 : 1.0–20.2 μ M ), with the n ‐butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n ‐butyl ester complex is more effective against leukemic patients′ blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of Ru II ‐based compounds.
Author Misirlić-Denčić, Sonja
Jovanović, Maja
Trajković, Vladimir
Dulović, Marija
Sabo, Tibor J.
Marković, Ivanka
Poljarević, Jelena M.
Bogdanović, Andrija
Savić, Aleksandar
Grgurić-Šipka, Sanja
Author_xml – sequence: 1
  givenname: Aleksandar
  surname: Savić
  fullname: Savić, Aleksandar
  organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia)
– sequence: 2
  givenname: Marija
  surname: Dulović
  fullname: Dulović, Marija
  organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia)
– sequence: 3
  givenname: Jelena M.
  surname: Poljarević
  fullname: Poljarević, Jelena M.
  organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia)
– sequence: 4
  givenname: Sonja
  surname: Misirlić-Denčić
  fullname: Misirlić-Denčić, Sonja
  organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia)
– sequence: 5
  givenname: Maja
  surname: Jovanović
  fullname: Jovanović, Maja
  organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia)
– sequence: 6
  givenname: Andrija
  surname: Bogdanović
  fullname: Bogdanović, Andrija
  organization: Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr. Koste Todorovića 2, 11000 Belgrade (Serbia)
– sequence: 7
  givenname: Vladimir
  surname: Trajković
  fullname: Trajković, Vladimir
  organization: Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Dr. Subotića 1, 11000 Belgrade (Serbia)
– sequence: 8
  givenname: Tibor J.
  surname: Sabo
  fullname: Sabo, Tibor J.
  organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia)
– sequence: 9
  givenname: Sanja
  surname: Grgurić-Šipka
  fullname: Grgurić-Šipka, Sanja
  email: sanjag@chem.bg.ac.rs
  organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia)
– sequence: 10
  givenname: Ivanka
  surname: Marković
  fullname: Marković, Ivanka
  email: ivanka@med.bg.ac.rs
  organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21805645$$D View this record in MEDLINE/PubMed
BookMark eNqFkc2O0zAQxy20iP2AK0fkGxdcbMdOnGOV_YBSirQscLS89pQaEqfEDttw2gvPwHvwSPskpOpSceM0M9bv95c1c4wOQhsAoaeMThil_KVtnJ1wyrZDxh-gI6ZySgqmioN9X5SH6DjGL5QKoZh6hA45U1TmQh6hX--HkFYQfcQmOOzD3e3P7z51LZ6G5K0JFjo8tcmPjwNul_iyH_Hg-4ZUQwMBcNU26xo2EPGNTytcDbZuV7AZanLeh1Fsg6n9D3D4LK2GejScN40PQBYvFne3v8k4WkgmAbka1oDn_vP4kfgYPVyaOsKT-3qCPpyfXVWvyPzdxetqOic2Y5yTXMmy4O6a01yWUMhSCmeMyuUShFvmLJPUZQBKGCcEZ4KWKs-kKilQJZyj2Ql6vstdd-23HmLSjY8W6toEaPuoVSmVlEXBR3KyI23XxtjBUq8735hu0Izq7fr19hZ6f4tReHYf3V834Pb43-WPQLkDbnwNw3_idPX2tPo3nOxcHxNs9q7pvuq8yAqpPy0u9OxSfZyV8zd6lv0Breuq3A
CitedBy_id crossref_primary_10_1149_2_1121810jes
crossref_primary_10_1002_aoc_3401
crossref_primary_10_1021_acs_jced_2c00318
crossref_primary_10_1007_s11094_015_1184_1
crossref_primary_10_1016_j_leukres_2015_06_013
crossref_primary_10_1039_C7NJ04416J
crossref_primary_10_1016_j_ccr_2014_08_002
crossref_primary_10_1080_00958972_2017_1282611
crossref_primary_10_1021_ic500825j
crossref_primary_10_1016_j_ica_2022_120797
crossref_primary_10_1016_j_jinorgbio_2013_08_002
crossref_primary_10_2174_0929867325666181031114306
crossref_primary_10_3390_inorganics11120460
crossref_primary_10_1016_j_ijbiomac_2012_01_030
crossref_primary_10_1016_j_jorganchem_2013_08_041
crossref_primary_10_1021_acs_organomet_5b00041
crossref_primary_10_1016_j_jorganchem_2016_06_024
crossref_primary_10_1016_j_ejmech_2014_05_060
crossref_primary_10_1002_open_202200019
Cites_doi 10.1006/abio.1996.0383
10.1038/nrm1496
10.1007/s00432-004-0617-0
10.1021/jm010051m
10.1006/excr.2000.4833
10.1021/bi034933u
10.1073/pnas.0800076105
10.1002/ijc.21080
10.1016/S0010-8545(02)00025-5
10.1016/0020-1693(94)04159-8
10.1002/cmdc.201000058
10.1002/chem.200600110
10.1016/j.biochi.2009.03.017
10.1021/ja027719m
10.1016/0065-2571(84)90007-4
10.1002/chem.200304724
10.1039/c0sc00175a
10.1039/b905798f
10.1002/asia.200800149
10.1084/jem.182.5.1545
10.1016/j.jinorgbio.2010.05.002
10.1021/ic50211a024
10.1146/annurev.biochem.68.1.383
10.1016/S0022-328X(97)00776-6
10.1039/B712656P
10.1039/b508531b
10.1039/b904071d
10.1016/j.drup.2006.05.002
10.1046/j.1432-1327.2000.01121.x
10.1016/j.molmed.2006.07.007
10.1016/j.jinorgbio.2006.02.013
ContentType Journal Article
Copyright Copyright © 2011 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Copyright_xml – notice: Copyright © 2011 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
– notice: Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/cmdc.201100232
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1860-7187
EndPage 1891
ExternalDocumentID 10_1002_cmdc_201100232
21805645
CMDC201100232
ark_67375_WNG_JR8VJ9LK_J
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Ministry of Science of the Republic of Serbia
  funderid: 41025; 172035
GroupedDBID ---
05W
0R~
1L6
1OC
29B
33P
3WU
4.4
53G
5GY
66C
6J9
77Q
8-0
8-1
A00
AAESR
AAHHS
AANLZ
AASGY
AAXRX
AAZKR
ABCUV
ABIJN
ABJNI
ABLJU
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFRAH
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
ASPBG
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
BSCLL
CS3
DCZOG
DR2
DRFUL
DRSTM
DU5
EBS
EJD
F5P
FEDTE
G-S
GODZA
HBH
HGLYW
HHZ
HVGLF
HZ~
IX1
LATKE
LAW
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MXFUL
MXSTM
MY~
O9-
OIG
P2W
P4E
PQQKQ
ROL
RWI
SUPJJ
W99
WBKPD
WXSBR
WYJ
XV2
YZZ
ZZTAW
~S-
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c3122-685972db20659e75954daa865fe4df61350d3ee84ad44214098635890e084dd03
IEDL.DBID DR2
ISSN 1860-7179
IngestDate Thu Jul 25 09:37:13 EDT 2024
Fri Aug 23 01:12:01 EDT 2024
Sat Sep 28 07:48:54 EDT 2024
Sat Aug 24 00:52:57 EDT 2024
Wed Oct 30 09:58:20 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3122-685972db20659e75954daa865fe4df61350d3ee84ad44214098635890e084dd03
Notes istex:C8959A8351211DA42277CFE9523F5877A0449389
ark:/67375/WNG-JR8VJ9LK-J
ArticleID:CMDC201100232
Ministry of Science of the Republic of Serbia - No. 41025; No. 172035
These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21805645
PQID 895855772
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_895855772
crossref_primary_10_1002_cmdc_201100232
pubmed_primary_21805645
wiley_primary_10_1002_cmdc_201100232_CMDC201100232
istex_primary_ark_67375_WNG_JR8VJ9LK_J
PublicationCentury 2000
PublicationDate 2011-10-04
October 4, 2011
2011-Oct-04
20111004
PublicationDateYYYYMMDD 2011-10-04
PublicationDate_xml – month: 10
  year: 2011
  text: 2011-10-04
  day: 04
PublicationDecade 2010
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
PublicationTitle ChemMedChem
PublicationTitleAlternate ChemMedChem
PublicationYear 2011
Publisher WILEY-VCH Verlag
WILEY‐VCH Verlag
Publisher_xml – name: WILEY-VCH Verlag
– name: WILEY‐VCH Verlag
References M. J. Clarke, Coord. Chem. Rev. 2002, 232, 69-93.
C. G. Hartinger, S. Zorbas-Seifried, M. A. Jakupec, B. Kynast, H. Zorbas, B. K. Keppler, J. Inorg. Biochem. 2006, 100, 891-904.
T. T. Yang, P. Sinai, S. R. Kain, Anal. Biochem. 1996, 241, 103-108.
V. Brabec, O. Nováková, Drug Resist. Updates 2006, 9, 111-22.
R. A. Vilaplana, F. Gonzalez-Vilchez, E. Gutierrez-Puebla, C. Ruiz-Valero, Inorg. Chim. Acta 1994, 224, 15-18.
S. Dougan, A. Habtemariam, S. McHale, S. Parsons, P. Sadler, P. Natl. Acad. Sci. USA 2008, 105, 11628-11633.
W. C. Earnshaw, L. M. Martins, S. H. Kaufmann, Annu. Rev. Biochem. 1999, 68, 383-424.
H. K. Liu, F. Wang, J. A. Parkinson, J. Bella, P. J. Sadler, Chem. Eur. J. 2006, 12, 6151-6165.
A. Pizarro, P. Sadler, Biochimie 2009, 91, 1198-1211.
H. Chen, J. A. Parkinson, R. E. Morris, P. J. Sadler, J. Am. Chem. Soc. 2003, 125, 173-186.
T. C. Chou, P. Talalay, Adv. Enzyme Regul. 1984, 22, 27-55.
Y. K. Yan, M. Melchart, A. Habtemariam, P. Sadler, Chem. Commun. 2005, 4764-4776.
J. M. Lazić, L. Vučićević, S. Grgurić-Šipka, K. Janjetović, G. Kaluderović, M. Misirkić, M. Gruden-Pavlović, D. Popadić, R. Paschke, V. Trajković, T. Sabo, ChemMedChem 2010, 5, 881-889.
M. Loeffler, G. Kroemer, Exp. Cell Res. 2000, 256, 19-26.
M. A. Jakupec, M. Galanski, V. B. Arion, C. G. Hartinger, B. K. Keppler, Dalton Trans. 2008, 183-194.
F. Wang, H. Chen, S. Parsons, I. Oswald, J. E. Davidson, P. J. Sadler, Chem. Eur. J. 2003, 9, 5810-5820.
World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues (Eds: S. H. Swerdlow, E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele, J. W. Vardiman) IARC Press, Lyon, 2008.
A. Martínez, C. Rajapakse, R. A. Sánchez-Delgado, A. Varela-Ramirez A, C. Lema, R. J. R. J. Aguilera, J. Inorg. Biochem. 2010, 104, 967-977.
R. A. Krause, K. Krause, Inorg. Chem. 1980, 19, 2600-2603.
L. Messori, P. Orioli, D. Vullo, E. Alessio, E. Iengo, Eur. J. Biochem. 2000, 267, 1206-1213.
W. P. Roos, B. Kaina, Trends Mol. Med. 2006, 12, 440-50.
O. Nováková, H. Chen, O. Vrana, A. Rodger, P. J. Sadler, V. Brabec, Biochemistry 2003, 42, 11544-11554.
S. Kapitza, M. Pongratz, M. A. Jakupec, P. Heffeter, W. Berger, L. Lackinger, B. K. Keppler, B. Marian, J. Cancer Res. Clin. Oncol. 2005, 131, 101-110.
R. E. Morris, R. E. Aird, P. Murdoch, H. Chen, J. Cummings, N. D. Hughes, S. Parsons, A. Parkin, G. Boyd, D. Jodrell, P. J. Sadler, J. Med. Chem. 2001, 44, 3616-3621.
H. Liu, J. A. Parkinson, J. Bella, F. Wang, P. J. Sadler, Chem. Sci. 2010, 1, 258-270.
T. Gianferrara, I. Bratsos, E. Alessio, Dalton Trans. 2009, 7588-7598.
S. B. Jensen, S. J. Rodger, M. D. Spicer, J. Organomet. Chem. 1998, 556, 151-158.
A. Levina, A. Mitra, P. A. Lay, Metallomics 2009, 1, 458-470.
S. J. Martin, C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, D. R. Green, J. Exp. Med. 1995, 182, 1545-1556.
S. Riedl, Y. Shi, Nat. Rev. Mol. Cell Biol. 2004, 5, 897-907.
G. N. Kaludjerović, D. Miljković, M. Momčilović, V. M. Djinović, M. Mostarica Stojković, T. J. Sabo, V. Trajković, Int. J. Cancer 2005, 116, 479-486.
A. F. A. Peacock, P. J. Sadler, Chem. Asian J. 2008, 3, 1890-1899.
2005; 131
2006; 12
2000; 256
2010; 104
1984; 22
2002; 232
2006; 9
2005; 116
2009
1999; 68
2008
2004; 5
2005
2008; 105
2008; 3
1996; 241
1998; 556
2001; 44
1980; 19
1994; 224
2010; 1
2000; 267
2009; 91
2003; 9
2003; 125
2009; 1
2010; 5
2003; 42
1995; 182
2006; 100
e_1_2_6_31_2
e_1_2_6_30_2
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_12_2
e_1_2_6_13_2
e_1_2_6_10_2
e_1_2_6_11_2
e_1_2_6_32_2
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
e_1_2_6_20_2
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_1_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_27_2
e_1_2_6_26_2
(e_1_2_6_29_2) 2008
e_1_2_6_25_2
References_xml – volume: 42
  start-page: 11544
  year: 2003
  end-page: 11554
  publication-title: Biochemistry
– volume: 1
  start-page: 458
  year: 2009
  end-page: 470
  publication-title: Metallomics
– volume: 3
  start-page: 1890
  year: 2008
  end-page: 1899
  publication-title: Chem. Asian J.
– volume: 232
  start-page: 69
  year: 2002
  end-page: 93
  publication-title: Coord. Chem. Rev.
– volume: 5
  start-page: 881
  year: 2010
  end-page: 889
  publication-title: ChemMedChem
– volume: 131
  start-page: 101
  year: 2005
  end-page: 110
  publication-title: J. Cancer Res. Clin. Oncol.
– volume: 100
  start-page: 891
  year: 2006
  end-page: 904
  publication-title: J. Inorg. Biochem.
– volume: 241
  start-page: 103
  year: 1996
  end-page: 108
  publication-title: Anal. Biochem.
– volume: 44
  start-page: 3616
  year: 2001
  end-page: 3621
  publication-title: J. Med. Chem.
– start-page: 7588
  year: 2009
  end-page: 7598
  publication-title: Dalton Trans.
– volume: 12
  start-page: 6151
  year: 2006
  end-page: 6165
  publication-title: Chem. Eur. J.
– volume: 9
  start-page: 111
  year: 2006
  end-page: 22
  publication-title: Drug Resist. Updates
– volume: 9
  start-page: 5810
  year: 2003
  end-page: 5820
  publication-title: Chem. Eur. J.
– volume: 182
  start-page: 1545
  year: 1995
  end-page: 1556
  publication-title: J. Exp. Med.
– volume: 556
  start-page: 151
  year: 1998
  end-page: 158
  publication-title: J. Organomet. Chem.
– volume: 19
  start-page: 2600
  year: 1980
  end-page: 2603
  publication-title: Inorg. Chem.
– volume: 267
  start-page: 1206
  year: 2000
  end-page: 1213
  publication-title: Eur. J. Biochem.
– volume: 68
  start-page: 383
  year: 1999
  end-page: 424
  publication-title: Annu. Rev. Biochem.
– start-page: 4764
  year: 2005
  end-page: 4776
  publication-title: Chem. Commun.
– year: 2008
– volume: 125
  start-page: 173
  year: 2003
  end-page: 186
  publication-title: J. Am. Chem. Soc.
– start-page: 183
  year: 2008
  end-page: 194
  publication-title: Dalton Trans.
– volume: 105
  start-page: 11628
  year: 2008
  end-page: 11633
  publication-title: P. Natl. Acad. Sci. USA
– volume: 1
  start-page: 258
  year: 2010
  end-page: 270
  publication-title: Chem. Sci.
– volume: 116
  start-page: 479
  year: 2005
  end-page: 486
  publication-title: Int. J. Cancer
– volume: 224
  start-page: 15
  year: 1994
  end-page: 18
  publication-title: Inorg. Chim. Acta
– volume: 91
  start-page: 1198
  year: 2009
  end-page: 1211
  publication-title: Biochimie
– volume: 104
  start-page: 967
  year: 2010
  end-page: 977
  publication-title: J. Inorg. Biochem.
– volume: 256
  start-page: 19
  year: 2000
  end-page: 26
  publication-title: Exp. Cell Res.
– volume: 5
  start-page: 897
  year: 2004
  end-page: 907
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 12
  start-page: 440
  year: 2006
  end-page: 50
  publication-title: Trends Mol. Med.
– volume: 22
  start-page: 27
  year: 1984
  end-page: 55
  publication-title: Adv. Enzyme Regul.
– ident: e_1_2_6_30_2
  doi: 10.1006/abio.1996.0383
– ident: e_1_2_6_23_2
  doi: 10.1038/nrm1496
– ident: e_1_2_6_27_2
  doi: 10.1007/s00432-004-0617-0
– ident: e_1_2_6_13_2
  doi: 10.1021/jm010051m
– ident: e_1_2_6_26_2
  doi: 10.1006/excr.2000.4833
– ident: e_1_2_6_17_2
  doi: 10.1021/bi034933u
– volume-title: World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues
  year: 2008
  ident: e_1_2_6_29_2
– ident: e_1_2_6_9_2
  doi: 10.1073/pnas.0800076105
– ident: e_1_2_6_31_2
  doi: 10.1002/ijc.21080
– ident: e_1_2_6_7_2
  doi: 10.1016/S0010-8545(02)00025-5
– ident: e_1_2_6_5_2
  doi: 10.1016/0020-1693(94)04159-8
– ident: e_1_2_6_16_2
  doi: 10.1002/cmdc.201000058
– ident: e_1_2_6_18_2
  doi: 10.1002/chem.200600110
– ident: e_1_2_6_12_2
  doi: 10.1016/j.biochi.2009.03.017
– ident: e_1_2_6_15_2
  doi: 10.1021/ja027719m
– ident: e_1_2_6_32_2
  doi: 10.1016/0065-2571(84)90007-4
– ident: e_1_2_6_11_2
  doi: 10.1002/chem.200304724
– ident: e_1_2_6_14_2
  doi: 10.1039/c0sc00175a
– ident: e_1_2_6_1_2
  doi: 10.1039/b905798f
– ident: e_1_2_6_10_2
  doi: 10.1002/asia.200800149
– ident: e_1_2_6_21_2
  doi: 10.1084/jem.182.5.1545
– ident: e_1_2_6_24_2
  doi: 10.1016/j.jinorgbio.2010.05.002
– ident: e_1_2_6_4_2
  doi: 10.1021/ic50211a024
– ident: e_1_2_6_22_2
  doi: 10.1146/annurev.biochem.68.1.383
– ident: e_1_2_6_28_2
  doi: 10.1016/S0022-328X(97)00776-6
– ident: e_1_2_6_6_2
  doi: 10.1039/B712656P
– ident: e_1_2_6_2_2
  doi: 10.1039/b508531b
– ident: e_1_2_6_3_2
  doi: 10.1039/b904071d
– ident: e_1_2_6_19_2
  doi: 10.1016/j.drup.2006.05.002
– ident: e_1_2_6_8_2
  doi: 10.1046/j.1432-1327.2000.01121.x
– ident: e_1_2_6_20_2
  doi: 10.1016/j.molmed.2006.07.007
– ident: e_1_2_6_25_2
  doi: 10.1016/j.jinorgbio.2006.02.013
SSID ssj0044818
Score 2.113197
Snippet Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and...
Herein we describe the synthesis, characterization, and anticancer activity of novel p-cymeneruthenium(II) complexes containing methyl, ethyl, n-propyl, and...
Abstract Herein we describe the synthesis, characterization, and anticancer activity of novel p ‐cymeneruthenium(II) complexes containing methyl, ethyl, n...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1884
SubjectTerms Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - pharmacology
apoptosis
Apoptosis - drug effects
cancer
Cell Line, Tumor
Coordination Complexes - chemical synthesis
Coordination Complexes - pharmacology
Ethylenediamines - chemistry
Humans
leukemia
Ligands
mitochondrial depolarization
Neoplasms - drug therapy
ruthenium
Ruthenium - chemistry
Stereoisomerism
Structure-Activity Relationship
Title Synthesis and in vitro Anticancer Activity of Ruthenium-Cymene Complexes with Cyclohexyl-Functionalized Ethylenediamine-N,N′-diacetate-Type Ligands
URI https://api.istex.fr/ark:/67375/WNG-JR8VJ9LK-J/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcmdc.201100232
https://www.ncbi.nlm.nih.gov/pubmed/21805645
https://search.proquest.com/docview/895855772
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtNAFB2hsmHDo7xMSzULFDZx68f4tYzchiq0UVVa6G409oyL1cRGcYLirrJhj9Qv6C_wSfkS7rVrhyAkJNjZI9uasc99-t4zhLwBo-la0rT1yDSUzoTw9IjJQE-k6ykzFtIJsMH5eOgenrPBhXPxSxd_zQ_RJtxQMip9jQIuomJvRRoaj2VcUXCi2UElbNoe1nTtn7b8URB6VAk-03cNHeKWoGFtNKy99dvXrNJ9fMHzP7mc6x5sZYL6j4hoJl9XnlztzqbRbnz9G6_j_6zuMXl455_SXg2oJ-SeyjZJ56QmuC679GzVr1V0aYeerKivy6fk9kOZgUdZpAUVmaRptlx8-5pOJzntZZg0B4RNaC-ud6ygeUKrAvssnY2Xi5uwHIPipaihRmquCoo5YhqW8Sj_rOblaLn43gcrXCcv02sl6QGgDKwmNr-MYcVwwbA7XC5-wAEMxVhJiYMYa9Oj9BK7mp-R8_7BWXio320Coce2CYGy60PIY8nIwh_AynMCh0khfNdJFJMJOCOOIW2lfCYkYxbSd_ngQ_mBoQyfSWnYz8lGlmfqJaGxKT1DJMIUFu7SFQgAKSgsIaPIRhpBjbxtQMC_1FwfvGZ1tjh-D95-D410Koy0l4nJFVbIeQ7_NHzHB6f-x0Fw9J4PNEIbEHGQW_wZIzKVzwruBxCoORDbaORFDa72YeB1GUjyoxGrgshfJsPD4_2wPXv1LzdtkQdWU9vItsnGdDJTr8HZmkY7lUD9BJ0FKa4
link.rule.ids 315,783,787,1378,27938,27939,46308,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtNAFB2hdgEb3g_znAUKm7j1-7GM3IaQJlZVUmA3GnvGYDWxUZyguKts2CPxBfwCn5Qv4V67dhSEhAQ72_JYHs-5T997hpCXYDQdQ-imGumaVC3OXTWyhK8mwnGlHnNh-9jgPA6dwbk1_GA31YTYC1PzQ7QJN5SMSl-jgGNC-nDLGhrPRFxxcKLdAS28DzJv4iYGR2ctgxQEH1WKT_ccTYXIxW94GzXjcHf8jl3ax0-8-pPTuevDVkaof4tEzevXtScXB8tFdBBf_sbs-F_zu01uXrmotFdj6g65JrO7pHNac1yXXTrZtmwVXdqhp1v26_Ie-fG2zMCpLNKC8kzQNNusv35JF_Oc9jLMmwPI5rQX15tW0DyhVY19li5nm_X3oJyB7qWopKZyJQuKaWIalPE0_yRX5XSz_tYHQ1znL9NLKegxAA0MJ_a_zGDKcEPYDTfrn3AAl2IspsSLGG7TUfoRG5vvk_P-8SQYqFf7QKixqUOs7HgQ9RgiMvAfsHRt37YE555jJ9ISCfgjtiZMKT2LC8sykMHLAzfK8zWpeZYQmvmA7GV5Jh8RGuvC1XjCdW7gRl0-B5yCzuIiikxkElTIqwYF7HNN98FqYmeD4Xqwdj0U0qlA0t7G5xdYJOfa7H34mg3PvHdDf3TChgqhDYoYiC7-j-GZzJcF83yI1WwIbxTysEZX-zBwvDTk-VGIUWHkLy_DgvFR0J49_pdBL8j1wWQ8YqM34ckTcsNoSh2tp2RvMV_KZ-B7LaLnlXT9AgR4Lcg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtNAFB2hVkJsoDwbymMWKGzi1o_xaxk5DSVNo6i00N1o7BmD1cSp4gTFXWXDHokv4Bf4pHwJ99q1QxASEuzskW3N2Oc-fe8ZQl6B0XRMaVhaaOhKY0K4Wsikr8XScZURCWn72OB8MnCOzlnvwr74pYu_5IeoE24oGYW-RgG_kvHBmjQ0GsuooOBEswNKeJs5lo5FXZ3TmkAKYo8iw2d4jq5B4OJXtI26ebB5_4ZZ2sY3vPiTz7npwhY2qHuPiGr2ZenJ5f58Fu5H178RO_7P8nbI3RsHlbZLRN0nt1T6gDSHJcN13qJn64atrEWbdLjmvs4fku_v8hRcyizJqEglTdLV8svnZDad0HaKWXOA2JS2o3LLCjqJaVFhnybz8Wr5LcjHoHkpqqiRWqiMYpKYBnk0mnxSi3y0Wn7tghkus5fJtZL0EGAGZhO7X8awYrhg0Bqslj_gAIYiLKXEQQy2aT_5iG3Nj8h59_AsONJudoHQIsuASNnxIOYxZWjiH2Dl2r7NpBCeY8eKyRi8EVuXllIeE5IxE_m7PHCiPF9Xusek1K3HZCudpGqX0MiQri5iYQgTt-nyBaAUNJaQYWghj2CDvK5AwK9Ksg9e0jqbHL8Hr79HgzQLjNSXiekllsi5Nv8weMN7p977nt8_5r0GoRWIOAgu_o0RqZrMM-75EKnZENw0yJMSXPXDwO3SkeWnQcwCIn-ZDA9OOkF99vRfbnpJbg87Xd5_OzjeI3fMqs6RPSNbs-lcPQfHaxa-KGTrJ2lMLHc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+in+vitro+anticancer+activity+of+ruthenium-cymene+complexes+with+cyclohexyl-functionalized+ethylenediamine-N%2CN%27-diacetate-type+ligands&rft.jtitle=ChemMedChem&rft.au=Savi%C4%87%2C+Aleksandar&rft.au=Dulovi%C4%87%2C+Marija&rft.au=Poljarevi%C4%87%2C+Jelena+M&rft.au=Misirli%C4%87-Den%C4%8Di%C4%87%2C+Sonja&rft.date=2011-10-04&rft.eissn=1860-7187&rft.volume=6&rft.issue=10&rft.spage=1884&rft.epage=1891&rft_id=info:doi/10.1002%2Fcmdc.201100232&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1860-7179&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1860-7179&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1860-7179&client=summon